Mesoporous bioactive glasses: Structure characteristics, drug/growth factor delivery and bone regeneration application

Interface Focus

Volumn 2, Issue 3, 2012, Pages 292-306

  Wu, Chengtie ^a   Chang, Jiang ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Bioactivity; Bone tissue engineering; Drug growth factor delivery; Mesoporous bioglass scaffolds; Osteogenesis

Indexed keywords

EID: 84860872816     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2011.0121     Document Type: Review

References (103)

1. Misra, S. K. et al. 2010 Effect of nanoparticulate bioactive glass particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) composites. J. R. Soc. Interface 7, 453-465. (doi:10.1098/rsif.2009.0255)
2. Hench, L. L. & Thompson, I. 2010 Twenty-first century challenges for biomaterials. J. R. Soc. Interface 7(Suppl 4), S379-S391. (doi:10.1098/rsif.2010.0151.focus)
3. Chen, Q. Z., Thompson, I. D. & Boccaccini, A. R. 2006 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 27, 2414-2425. (doi:10.1016/j.biomaterials.2005.11.025)
4. Jones, J. R., Tsigkou, O., Coates, E. E., Stevens, M. M., Polak, J. M. & Hench, L. L. 2007 Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. Biomaterials 28, 1653-1663. (doi:10.1016/j.biomaterials.2006.11.022)
5. Jones, J. R., Ehrenfried, L. M. & Hench, L. L. 2006 Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials 27, 964-973. (doi:10.1016/j.biomaterials.2005.07.017)
6. Wu, Z. Y., Hill, R. G., Yue, S., Nightingale, D., Lee, P. D. & Jones, J. R. 2011 Melt-derived bioactive glass scaffolds produced by a gel-cast foaming technique. Acta Biomater. 7, 1807-1816. (doi:10.1016/j.actbio.2010.11.041)
7. Hench, L. L. 1991 Bioceramics: from concept to clinic. J. Am. Ceram. Soc. 74, 1487-1510. (doi:10.1111/j.1151-2916.1991.tb07132.x)
8. Hench, L. L. 1998 Biomaterials: a forecast for the future. Biomaterials 19, 1419-1423. (doi:10.1016/S0142-9612(98)00133-1)
9. Gough, J. E., Jones, J. R. & Hench, L. L. 2004 Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 25, 2039-2046. (doi:10.1016/j.biomaterials.2003.07.001)
10. Gough, J. E., Notingher, I. & Hench, L. L. 2004 Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths. J. Biomed. Mater. Res. A 68, 640-650. (doi:10.1002/jbm.a.20075)
11. Valerio, P., Pereira, M. M., Goes, A. M. & Leite, M. F. 2004 The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 25, 2941-2948. (doi:10.1016/j.biomaterials.2003.09.086)
12. Xynos, I. D., Edgar, A. J., Buttery, L. D., Hench, L. L. & Polak, J. M. 2000 Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem. Biophys. Res. Commun. 276, 461-465. (doi:10.1006/bbrc.2000.3503)
13. Hoppe, A., Guldal, N. S. & Boccaccini, A. R. 2011 A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 32, 2757-2774. (doi:10.1016/j.biomaterials.2011.01.004)
14. Wu, C., Chang, J. & Xiao, Y. 2011 Mesoporous bioactive glasses as drug delivery and bone tissue engineering platforms. Ther. Deliv. 2, 1189-1198. (doi:10.4155/tde.11.84)
15. Hench, L. L. & Polak, J. M. 2002 Third-generation biomedical materials. Science 295, 1014-1017. (doi:10.1126/science.1067404)
16. Arcos, D. & Vallet-Regi, M. 2010 Sol-gel silica-based biomaterials and bone tissue regeneration. Acta Biomater. 6, 2874-2888. (doi:10.1016/j.actbio.2010.02.012)
17. Abou Neel, E. A., Chrzanowski, W. & Knowles, J. C. 2008 Effect of increasing titanium dioxide content on bulk and surface properties of phosphate-based glasses. Acta Biomater. 4, 523-534. (doi:10.1016/j.actbio.2007.11.007)
18. Abou Neel, E. A., Chrzanowski, W., Valappil, S. P., O'Dell, L. A., Pickup, D. M., Smith, M. E., Newport, R. J. & Knowles, J. C. 2009 Doping of a high calcium oxide metaphosphate glass with titanium dioxide. J. Non-Cryst. Solids 355, 991-1000. (doi:10.1016/j.jnoncrysol.2009.04.016)
19. Abou Neel, E. A., Ahmed, I., Blaker, J. J., Bismarck, A., Boccaccini, A. R., Lewis, M. P., Nazhat, S. N. & Knowles, J. C. 2005 Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres. Acta Biomater. 1, 553-563. (doi:10.1016/j.actbio.2005.05.001)
20. Pietak, A. M., Reid, J. W., Stott, M. J. & Sayer, M. 2007 Silicon substitution in the calcium phosphate bioceramics. Biomaterials 28, 4023-4032. (doi:10.1016/j.biomaterials.2007.05.003)
21. Bohner, M. 2009 Silicon-substituted calcium phosphates: a critical view. Biomaterials 30, 6403-6406. (doi:10.1016/j.biomaterials.2009.08.007)
22. Mastrogiacomo, M., Muraglia, A., Komlev, V., Peyrin, F., Rustichelli, F., Crovace, A. & Cancedda, R. 2005 Tissue engineering of bone: search for a better scaffold. Orthod. Craniofac. Res. 8, 277-284. (doi:10.1111/j.1601-6343.2005.00350.x)
23. Laurencin, D. et al. 2011 Magnesium incorporation into hydroxyapatite. Biomaterials 32, 1826-1837. (doi:10.1016/j.biomaterials.2010.11.017)
24. Li, R., Clark, A. E. & Hench, L. L. 1991 An investigation of bioactive glass powders by sol-gel processing. J. Appl. Biomater. 2, 231-239. (doi:10.1002/jab.770020403)
25. Cerruti, M. & Sahai, N. 2006 Silicate biomaterials for orthopaedic and dental implants. Rev. Mineral. Geochem. 64, 283-313. (doi:10.2138/rmg.2006.64.9)
26. Zhong, J. & Greenspan, D. C. 2000 Processing and properties of sol-gel bioactive glasses. J. Biomed. Mater. Res. 53, 694-701. (doi:10.1002/1097-4636(2000)53:6,694::AID-JBM12.3.0.CO;2-6)
27. Hamadouche, M., Meunier, A., Greenspan, D. C., Blanchat, C., Zhong, J. P., La Torre, G. P. & Sedel, L. 2001 Long-term in vivo bioactivity and degradability of bulk sol-gel bioactive glasses. J. Biomed. Mater. Res. 54, 560-566. (doi:10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.0.CO;2-J)
28. Arcos, D., Lopez-Noriega, A., Ruiz-Hernandez, E., Terasaki, O. & Vallet-Regi, M. 2009 Ordered mesoporous microspheres for bone grafting and drug delivery. Chem. Mater. 21, 1000-1009. (doi:10.1021/cm801649z)
29. Zhao, D., Feng, J., Huo, Q., Melosh, N., Fredrickson, G. H., Chmelka, B. F. & Stucky, G. D. 1998 Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279, 548-552. (doi:10.1126/science.279.5350.548)
30. Lopez-Noriega, A., Arcos, D., Izquierdo-Barb, I., Sakamoto, Y., Terasaki, O. & Vallet-Regi, M. 2006 Ordered mesoporous bioactive glasses for bone tissue regeneration. Chem. Mater. 18, 3137-3144. (doi:10.1021/cm060488o)
31. Vallet-Regi, M. 2006 Revisiting ceramics for medical applications. Dalton Trans. 5211-5220. (doi:10.1039/b610219k)
32. Vallet-Regi, M. A., Ruiz-Gonzalez, L., Izquierdo-Barba, I. & Gonzalez-Calbet, J. M. 2006 Revisiting silica based ordered mesoporous materials: medical applications. J. Mater. Chem. 16, 26-31. (doi:10.1039/b509744d)
33. Manzanoab, M. & Vallet-Regi, M. 2010 New developments in ordered mesoporous materials for drug delivery. J. Mater. Chem. 20, 5593-5604. (doi:10.1039/b922651f)
34. Vallet-Regi, M., Balas, F. & Arcos, D. 2007 Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. Engl. 46, 7548-7558. (doi:10.1002/anie.200604488)
35. Horcajada, P., Ramila, A., Boulahya, K., Gonzalez-Calbet, J. & Vallet-Regi, M. 2004 Bioactivity in ordered mesoporous materials. Solid State Sci. 6, 1295-1300. (doi:10.1016/j.solidstatesciences.2004.07.026)
36. Izquierdo-Barba, I., Ruiz-Gonzalez, L., Doadrio, J. C., Gonzalez-Calbet, J. M. & Vallet-Regi, M. 2005 Tissue regeneration: a new property of mesoporous materials. Solid State Sci. 7, 983-989. (doi:10.1016/j.solidstatesciences.2005.04.003)
37. Zhao, L. Z., Yan, X. X., Zhou, X. F., Zhou, L., Wang, H. N., Tang, H. W. & Yu, C. Z. 2008 Mesoporous bioactive glasses for controlled drug release. Microporous Mesoporous Mater. 109, 210-215. (doi:10.1016/j.micromeso.2007.04.041)
38. Mourino, V. & Boccaccini, A. R. 2009 Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J. R. Soc. Interface 7, 209-227. (doi:10.1098/rsif.2009.0379)
39. Zhu, Y., Zhang, Y., Wu, C., Fang, Y., Wang, J. & Wang, S. 2011 The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds. Microporous Mesoporous Mater. 143, 311-319. (doi:10.1016/j.micromeso.2011.03.007)
40. Vallet-Regi, M. 2006 Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem. Eur. J. 12, 5934-5943. (doi:10.1002/chem.200600226)
41. Yan, X., Yu, C., Zhou, X., Tang, J. & Zhao, D. 2004 Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew. Chem. Int. Ed. Engl. 43, 5980-5984. (doi:10.1002/anie.200460598)
42. Yan, X., Huang, X., Yu, C., Deng, H., Wang, Y., Zhang, Z., Qiao, S., Lu, G. & Zhao, D. 2006 The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 27, 3396-3403. (doi:10.1016/j.biomaterials.2006.01.043)
43. Leonova, E., Izquierdo-Barba, I., Arcos, D., Lopez-Noriega, A., Hedin, N., Vallet-Regi, M. & Eden, M. 2008 Multinuclear solid-state NMR studies of ordered mesoporous bioactive glasses. J. Phys. Chem. C 112, 5552-5562. (doi:10.1021/jp7107973)
44. 5 mesoporous bioactive glasses. Chem. Mater. 21, 5474-5484. (doi:10.1021/cm9022776)
45. Alcaide, M., Portoles, P., Lopez-Noriega, A., Arcos, D., Vallet-Regi, M. & Portoles, M. T. 2010 Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes, demonstrating its biocompatibility as a potential bone graft material. Acta Biomater. 6, 892-899. (doi:10.1016/j.actbio.2009.09.008)
46. Brinker, C. J., Lu, Y. F., Sellinger, A. & Fan, H. Y. 1999 Evaporation-induced self-assembly: nanostructures made easy. Adv. Mater. 11, 579-585. (doi:10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R)
47. Xia, W. & Chang, J. 2006 Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J. Control. Release 110, 522-530. (doi:10.1016/j.jconrel.2005.11.002)
48. Zhu, Y., Wu, C., Ramaswamy, Y., Kockrick, E., Simon, P., Kaskel, S. & Zreiqat, H. 2008 Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Microporous Mesoporous Mater. 112, 494-503. (doi:10.1016/j.micromeso.2007.10.029)
49. Li, X., Wang, X. P., Chen, H. R., Jiang, P., Dong, X. P. & Shi, J. L. 2007 Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach. Chem. Mater. 19, 4322-4326. (doi:10.1021/cm0708564)
50. Wu, C., Miron, R., Sculeaan, A., Kaskel, S., Doert, T., Schulze, R. & Zhang, Y. 2011 Proliferation, differentiation and gene expression of osteoblasts in boroncontaining associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials 32, 7068-7078. (doi:10.1016/j.biomaterials.2011.06.009)
51. Wu, C., Zhang, Y., Zhu, Y., Friis, T. & Xiao, Y. 2010 Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials 31, 3429-3438. (doi:10.1016/j.biomaterials.2010.01.061)
52. Wu, X., Wei, J., Lu, X., Lv, Y., Chen, F., Zhang, Y. & Liu, C. 2010 Chemical characteristics and hemostatic performances of ordered mesoporous calcium-doped silica xerogels. Biomed. Mater. 5, 035006. (doi:10.1088/1748-6041/5/3/035006)
53. Wang, J. Q., Yan, P. H., Liu, S., Ou, J. F., Lei, Z. Q. & Yang, S. R. 2010 'Green' synthesis of highly ordered mesoporous bioactive glass using acetic anhydride as the catalyst. J. Non-Cryst. Solids 356, 1514-1518. (doi:10.1016/j.jnoncrysol.2010.05.058)
54. Yun, H. S., Kim, S. E. & Hyun, Y. T. 2008 Preparation of 3D cubic ordered mesoporous bioactive glasses. Solid State Sci. 10, 1083-1092. (doi:10.1016/j.solidstatesciences.2007.11.037)
55. 5 system with tailored hierarchical mesomacroporosity. Acta Biomater. 7, 1265-1273. (doi:10.1016/j.actbio.2010.10.006)
56. Yun, H. S., Kim, S. E. & Hyun, Y. T. 2009 Preparation of bioactive glass ceramic beads with hierarchical pore structure using polymer self-assembly technique. Mater. Chem. Phys. 115, 670-676. (doi:10.1016/j.matchemphys.2009.02.001)
57. Yu, C. Z., Yan, X. X., Wei, G. F., Zhao, L. Z., Yi, J., Deng, H. X., Wang, L. Z. & Lu, G. Q. 2010 Synthesis and in vitro bioactivity of ordered mesostructured bioactive glasses with adjustable pore sizes. Microporous Mesoporous Mater. 132, 282-289. (doi:10.1016/j.micromeso.2010.03.009)
58. Yun, H. S., Kim, S. H., Lee, S. & Song, I. H. 2010 Synthesis of high surface area mesoporous bioactive glass nanospheres. Mater. Lett. 64, 1850-1853. (doi:10.1016/j.matlet.2010.04.053)
59. Wu, C., Fan, W., Chang, J. & Xiao, Y. Submitted. Mesoporous bioglass nanospheres for anti-cancer drug delivery.
60. 5 mesoporous microspheres. Microporous Mesoporous Mater. 135, 67-73. (doi:10.1016/j.micromeso.2010.06.012)
61. Hong, Y., Chen, X., Jing, X., Fan, H., Guo, B., Gu, Z. & Zhang, X. 2010 Preparation, bioactivity, and drug release of hierarchical nanoporous bioactive glass ultrathin fibers. Adv. Mater. 22, 754-758. (doi:10.1002/adma.200901656)
62. Wu, C., Zhang, Y., Ke, X., Xie, Y., Zhu, H., Crawford, R. & Xiao, Y. 2010 Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification. J. Biomed. Mater. Res. A 95, 476-485. (doi:10.1002/jbm.a.32873)
63. Wu, C., Zhou, Y., Fan, W., Han, P., Chang, J., Yuen, J., Zhang, M. & Xiao, Y. 2012 Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials 33, 2076-2085. (doi:10.1016/j.biomaterials.2011.11.042)
64. Lei, B., Chen, X. F., Wang, Y. J., Zhao, N., Du, C. & Zhang, L. M. 2009 Acetic acid derived mesoporous bioactive glasses with an enhanced in vitro bioactivity. J. Non-Cryst. Solids 355, 2583-2587. (doi:10.1016/j.jnoncrysol.2009.09.014)
65. Xia, W. & Chang, J. 2008 Preparation, in vitro bioactivity and drug release property of well-ordered mesoporous 58S bioactive glass. J. Non-Cryst. Solids 15, 1338-1341. (doi:10.1016/j.jnoncrysol.2006.10.084)
66. 5 (M1/4Mg, Zn, Cu) bioactive glasses/composites. J. Mater. Chem. 18, 4103-4109. (doi:10.1039/b805114c)
67. Feng, X. & Chang, J. 2011 Synthesis of a well-ordered mesoporous 58S bioactive glass by a simple method. Int. J. Appl. Ceram. Technol. 8, 547-552. (doi:10.1111/j.1744-7402.2010.02596.x)
68. Hong, Y. L., Chen, X. S., Jing, X. B., Fan, H. S., Gu, Z. W. & Zhang, X. D. 2010 Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers. Adv. Funct. Mater. 20, 1503-1510. (doi:10.1002/adfm.200901627)
69. Lei, B., Chen, X. F., Wang, Y. J. & Zhao, N. 2009 Synthesis and in vitro bioactivity of novel mesoporous hollow bioactive glass microspheres. Mater. Lett. 63, 1719-1721. (doi:10.1016/j.matlet.2009.04.041)
70. 3+ doped calcium silicate microspheres as drug carriers via a template route. Dalton Trans. 40, 1873-1879. (doi:10.1039/c0dt01390k)
71. Yun, H., Kim, S. E., Hyun, Y. T., Heo, S. & Shin, J. 2008 Hierarchically mesoporous-macroporous bioactive glasses scaffolds for bone tissue regeneration. J. Biomed. Mater. Res. B 87B, 374-380. (doi:10.1002/jbm.b.31114)
72. 2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties. Acta Biomater. 7, 1797-1806. (doi:10.1016/j.actbio.2010.12.018)
73. Wu, C., Fan, W., Zhu, Y., Gelinsky, M., Chang, J., Cuniberti, G., Albrecht, V., Friis, T. & Xiao, Y. 2011 Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure. Acta Biomater. 7, 3563-3572. (doi:10.1016/j.actbio.2011.06.028)
74. Franco, J., Hunger, P., Launey, M. E., Tomsia, A. P. & Saiz, E. 2010 Direct write assembly of calcium phosphate scaffolds using a water-based hydrogel. Acta Biomater. 6, 218-228. (doi:10.1016/j.actbio.2009.06.031)
75. Miranda, P., Pajares, A., Saiz, E., Tomsia, A. P. & Guiberteau, F. 2008 Mechanical properties of calcium phosphate scaffolds fabricated by robocasting. J. Biomed. Mater. Res. A 85A, 218-227. (doi:10.1002/jbm.a.31587)
76. Miranda, P., Saiz, E., Gryn, K. & Tomsia, A. P. 2006 Sintering and robocasting of b-tricalcium phosphate scaffolds for orthopaedic applications. Acta Biomater. 2, 457-466. (doi:10.1016/j.actbio.2006.02.004)
77. Yun, H. S., Kim, S. E. & Hyeon, Y. T. 2007 Design and preparation of bioactive glasses with hierarchical pore networks. Chem. Commun. 2139-2141. (doi:10.1039/b702103h)
78. Wu, C., Luo, Y., Cuniberti, G., Xiao, Y. & Gelinsky, M. 2011 Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 7, 2644-2650. (doi:10.1016/j.actbio.2011.03.009)
79. Li, X., Wang, X., Zhang, L., Chen, H. & Shi, J. 2009 MBG/PLGA composite microspheres with prolonged drug release. J. Biomed. Mater. Res. B 89B, 148-154. (doi:10.1002/jbm.b.31197)
80. Li, X., Shi, J., Dong, X., Zhang, L. & Zeng, H. 2008 A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J. Biomed. Mater. Res. A 84A, 84-91. (doi:10.1002/jbm.a.31371)
81. Wei, J., Chen, F., Shin, J. W., Hong, H., Dai, C., Su, J. & Liu, C. 2009 Preparation and characterization of bioactive mesoporous wollastonite: polycaprolactone composite scaffold. Biomaterials 30, 1080-1088. (doi:10.1016/j.biomaterials.2008.10.046)
82. Zhu, M., Zhang, L. X., He, Q. J., Zhao, J. J., Guo, L. M. & Shi, J. L. 2011 Mesoporous bioactive glass-coated poly(L-lactic acid) scaffolds: a sustained antibiotic drug release system for bone repairing. J. Mater. Chem. 21, 1064-1072. (doi:10.1039/c0jm02179b)
83. Zhu, H., Wu, B., Feng, X. & Chen, J. 2011 Preparation and characterization of bioactive mesoporous calcium silicate-silk fibroin composite films. J. Biomed. Mater. Res. B 98B, 330-341. (doi:10.1002/jbm.b.31856)
84. Xia, W., Chang, J., Lin, J. & Zhu, J. 2008 The pH-controlled dual-drug release from mesoporous bioactive glass/polypeptide graft copolymer nanomicelle composites. Eur. J. Pharm. Biopharm. 69, 546-552. (doi:10.1016/j.ejpb.2007.11.018)
85. Wu, C., Ramaswamy, Y., Zhu, Y., Zheng, R., Appleyard, R., Howard, A. & Zreiqat, H. 2009 The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL-lactide-co-glycolide) films. Biomaterials 30, 2199-2208. (doi:10.1016/j.biomaterials.2009.01.029)
86. Wu, C., Zhu, Y., Chang, J., Zhang, Y. & Xiao, Y. 2010 Bioactive inorganic-materials/alginate composite microspheres with controllable drug-delivery ability. J. Biomed. Mater. Res. B 94B, 32-43. (doi:10.1002/jbm.b.31621)
87. Wu, C., Zhang, Y., Zhou, Y., Fan, W. & Xiao, Y. 2011 A comparative study of mesoporous-glass/silk and nonmesoporous-glass/silk scaffolds: physiochemistry and in vivo osteogenesis. Acta Biomater. 7, 2229-2236. (doi:10.1016/j.actbio.2010.12.019)
88. Li, X., Wang, X. P., Hua, Z. L. & Shi, J. L. 2008 One-pot synthesis of magnetic and mesoporous bioactive glass composites and their sustained drug release property. Acta Mater. 56, 3260-3265. (doi:10.1016/j.actamat.2008.03.013)
89. 5 (M1/4Zr, Mg, Sr) mesoporous bioactive glass (MBG) scaffolds. J. Mater. Chem. 21, 9208-9218. (doi:10.1039/c1jm10838g)
90. Salinas, A. J., Shruti, S., Malavasi, G., Menabue, L. & Vallet-Regi, M. 2011 Substitutions of cerium, gallium and zinc in ordered mesoporous bioactive glasses. Acta Biomater. 7, 3452-3458. (doi:10.1016/j.actbio.2011.05.033)
91. Zhu, Y. F. & Kaskel, S. 2009 Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous Mesoporous Mater. 118, 176-182. (doi:10.1016/j.micromeso.2008.08.046)
92. Zhao, Y. F., Loo, S. C., Chen, Y. Z., Boey, F. Y. & Ma, J. 2008 In situ SAXRD study of solgel induced well-ordered mesoporous bioglasses for drug delivery. J. Biomed. Mater. Res. A 85A, 1032-1042. (doi:10.1002/jbm.a.31545)
93. Lin, J., Fan, Y., Yang, P. P., Huang, S. S., Jiang, J. H. & Lian, H. Z. 2009 Luminescent and mesoporous europiumdoped bioactive glasses (MBG) as a drug carrier. J. Phys. Chem. C 113, 7826-7830. (doi:10.1021/jp900515x)
94. 3+) as a drug carrier. J. Colloid Interface Sci. 357, 280-285. (doi:10.1016/j.jcis.2011.01.109)
95. Lopez-Noriega, A., Arcos, D. & Vallet-Regi, M. 2010 Functionalizing mesoporous bioglasses for long-term anti-osteoporotic drug delivery. Chem. Eur. J. 16, 10879-10886. (doi:10.1002/chem.201000137)
96. Lin, H. M., Wang, W. K., Hsiung, P. A. & Shyu, S. G. 2010 Light-sensitive intelligent drug delivery systems of coumarin-modified mesoporous bioactive glass. Acta Biomater. 6, 3256-3263. (doi:10.1016/j.actbio.2010.02.014)
97. Wu, C., Fan, W., Chang, J. & Xiao, Y. Submitted. Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factor.
98. Dai, C., Guo, H., Lu, J., Shi, J., Wei, J. & Liu, C. 2011 Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based muCT. Biomaterials 32, 8506-8517. (doi:10.1016/j.biomaterials.2011.07.090)
99. Wu, C., Fan, W., Gelinsky, M., Xiao, Y., Chang, J., Friis, T. & Cuniberti, G. 2011 In situ preparation and protein delivery of silicate-alginate composite microspheres with core-shell structure. J. R. Soc. Interface 8, 1804-1814. (doi:10.1098/rsif.2011.0201)
100. Fan, W., Wu, C., Han, P., Zhou, Y. & Xiao, Y. Submitted. Porous Ca-Si-based nanospheres: a potential intra-canal disinfectant for infected canal treatment.
101. Deng, Y., Li, X. K. & Li, Q. 2009 Effect of pore size on the growth of hydroxyapatite from mesoporous CaO-SiO2 substrate. Ind. Eng. Chem. Res. 48, 8829-8836. (doi:10.1021/ie801796y)
102. Yu, C. Z., Wei, G. F., Yan, X. X., Yi, J., Zhao, L. Z., Zhou, L. & Wang, Y. H. 2011 Synthesis and in-vitro bioactivity of mesoporous bioactive glasses with tunable macropores. Microporous Mesoporous Mater. 143, 157-165. (doi:10.1016/j.micromeso.2011.02.024)
103. 13C solidstate NMR. J. Phys. Chem. C 114, 19345-19356. (doi:10.1021/jp105408c)